Efficacy and safety of GLP-1 receptor agonists in patients with metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH): A systematic review and meta-analysis.
Alfawaz M, Bajamaan D, Alghamdi L, Alorfi Y, Khared S, Ameen N, Alamri R, Abuladel M, Alshehri R, Altowairqi S
The online reader was unable to display this document directly. This may occur if the repository host is temporarily unreachable, or if security restrictions (CORS) prevent embedded viewing.